SECOND WAIVER TO NOTE PURCHASE AGREEMENTNote Purchase Agreement • August 10th, 2016 • PERRIGO Co PLC • Pharmaceutical preparations
This SECOND WAIVER TO NOTE PURCHASE AGREEMENT dated as of June 7, 2016 (this “Waiver”) to the Note Purchase Agreement (as defined below) is between Omega Pharma N.V., a company incorporated with limited liability in Belgium (the “Company”), and each of the institutions which is a signatory to this Waiver (collectively, the “Noteholders”).
Re: Waiver to Note Purchase AgreementPERRIGO Co PLC • August 10th, 2016 • Pharmaceutical preparations
Reference is hereby made to that Waiver to Note Purchase Agreement dated as of May 16, 2016 between Omega Pharma N.V. (the “Company”) and each of the Noteholders party thereto, as the same may be amended, restated, modified or supplemented from time to time (as amended, the "Waiver"). Capitalized terms which are used herein without definition and which are defined in the Waiver shall have the same meanings herein as in the Waiver.
